MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ROBAIRE, B.
Right arrow Articles by KATO, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ROBAIRE, B.
Right arrow Articles by KATO, G.

Molecular Pharmacology, Vol 11, 722-734, Copyright © 1975 by the American Society for Pharmacology and Experimental Therapeutics

Effects of Edrophonium, Eserine, Decamethonium, d-Tubocurarine, and Gallamine on the Kinetics of Membrane-Bound and Solubilized Eel Acetylcholinesterase

B. ROBAIRE 1 and G. KATO 1

1 Departments of Pharmacology and Therapeutics and of Research in Anaesthesis, McGill Unversity, Montreal 109, Quebec, Canada

The effects of edrophonium, eserine, decamethonium, d-tubocurarine, and gallamine on the kinetic parameters of membrane-bound and solubilized eel acetylcholinesterase were investigated. All assays were done using acetylcholine as substrate with a pH-stat in Ringer's solution. Edrophonium, an inhibitor of the anionic portion of the active site of acetylcholinesterase, was found to be a competitive inhibitor at a concentration of 0.1 µM and a mixed competitive-noncompetitive inhibitor at higher concentrations (1 and 10 µM) for both membrane-bound and solubilized acetylcholinesterase. Eserine (0.2-20 µM), a molecule which interacts with both the anionic and the esteratic portion of the active site of acetylcholinesterase, was a competitive inhibitor of the solubilized enzyme; inhibition by eserine of the membrane-bound enzyme was noncompetitive at 0.2 µM and mixed competitive-noncompetitive at higher concentrations of eserine (2 and 20 µM). The inhibition by decamethonium of both membrane-bound and solubilized acetylcholinesterase was noncompetitive at 3 and 100 µM decamethonium. d-Tubocurarine was found to affect the kinetics of both states of the enzyme in a mixed competitive-noncompetitive fashion. Gallamine, at concentrations as high as 100 µM, had no significant effect on either the Km or Vmax of membrane-bound or solubilized acetylcholinesterase. The effects of the membrane matrix on the interaction of these drugs with eel acetylcholinesterase are discussed.

Note:
ACKNOWLEDGMENTS We would like to thank Dr. J. Richardson and Ms. T. Bouchard for taking the electron micrographs, and Mr. H. P. Decker of Hoffmann-La Roche for a generous gift of edrophonium chloride.

Submitted on July 9, 1974







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1975 by the American Society for Pharmacology and Experimental Therapeutics